Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 1/20 | 0.56 |
| ▸ | CNR2 | P34972 | 1/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.55 |
| ▸ | ATM | Q13315 | 1/20 | 0.55 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.54 |
| ▸ | GABRA1 | P14867 | 3/20 | 0.51 |
| ▸ | GABRB2 | P47870 | 3/20 | 0.51 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.51 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.51 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.51 |
| ▸ | GABRA2 | P47869 | 2/20 | 0.51 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.50 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.50 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.50 |
| ▸ | TRPM8 | Q7Z2W7 | 2/20 | 0.49 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28811157 | 1.00 | FAAH (0.56) | FAAHCNR2CYP3A4ATMSOAT1 | |
| SCHEMBL8392531 | 1.00 | FAAH (0.56) | FAAHCNR2CYP3A4ATMSOAT1 | |
| SCHEMBL8392526 | 1.00 | FAAH (0.56) | FAAHCNR2CYP3A4ATMSOAT1 | |
| SCHEMBL8393161 | 1.00 | FAAH (0.56) | FAAHCNR2CYP3A4ATMSOAT1 | |
| SCHEMBL5718457 | 1.00 | FAAH (0.56) | FAAHCNR2CYP3A4ATMSOAT1 | |
| SCHEMBL20382757 | 0.91 | CNR2 (0.47) | FAAHCNR2CYP3A4ATMSOAT1 | |
| SCHEMBL11011121 | 0.88 | CYP3A4 (0.62) | CYP3A4ATMSOAT1GABRA1GABRB2 | |
| SCHEMBL11011119 | 0.88 | CYP3A4 (0.62) | CYP3A4ATMSOAT1GABRA1GABRB2 | |
| SCHEMBL30525080 | 0.82 | FAAH (0.58) | FAAHCNR2CYP3A4ATMSOAT1 | |
| SCHEMBL11819169 | 0.81 | FAAH (0.55) | FAAHCNR2CYP3A4ATMSOAT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1562617-B1 | NEW USE OF PIPATALINE | COUNCIL SCIENT IND RES (IN) | 2006-12-20 | — | — | EP | disclosed |
| US-20060228432-A1 | alpha-glucosidase inhibitors from a natural source | RAO JANASWAMY M | 2006-10-12 | — | — | US | disclosed |
| US-7081260-B2 | α-Glucosidase inhibitors from a natural source | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2006-07-25 | — | — | US | disclosed |
| US-20040081711-A1 | alpha-Glucosidase inhibitors from a natural source | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2004-04-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060228432-A1 | alpha-glucosidase inhibitors from a natural source | GANAB, GBA3, GAA | FAAH 3412/4885CNR2 4793/4885CYP3A4 1542/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.